BRMS1 and benign neoplasm: In order to investigate whether BRMS1 expression is changed in glioma, we utilized a TMA to evaluate the BRMS1 expression in normal brain tissue, tumor adjacent normal brain tissue, benign tumor (Grade I and II) and malignant (Grade III and IV).